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A new nalriur~ti¢ pcp|ide, which exhibits the entire sl~'ctrum or actions known to be characteristic o[' a(rlal and I~min natrlurctic I~ptides fANP 
and BNP), was isolated from eel ¢~trdiae v~ntrieles and has been named ventrteular natriur©tic pcpttde (VNP~, The primary structure o fed  VNP 
is characterized by, its uniquely long C.lerminal 'tail'.lhal extends from the second half, eystine. Thus. eel VNP apl~ars to I~ a novel natriuretic 
p~ptide o f .  tYl~ not round in mammals, With respect ~o natriureliC (rat) and vasodepressor (rat and eel) activities, eel VNP is much marc potent 
than human ANP in eels and almost equipotent in rats, Stron~ tach~cphylaxis is observed for the v~tsodepressor eff~t in both rats and eels, whereas 
it is not observed for the natriuretic eft'cot in rats, 
Atrial natrturetic peptide: Cardiac ventricle: Natriur©sis; Hypotension: Tachyphylaxis; Eel; dnl~ut/lajapaniea 
1, INTRODUCTION 
Euryhaline fish are capable of  osmoregulation by 
changing their drinking rate, rate of intestinal absorp- 
tion, gill permeability, and rate of renal excretion, of 
water and electrolytes [1]. Among the euryhaline 
species, eels are one of the few that can survive a direct 
transfer from fresh water to seawater or vice versa The 
ways that they cope with the drastic changes in en- 
vironmental osmotic pressure have been studied in 
some detail, and data are accumulating that implicate 
ANP in fish osmoregulation [2-5]. However, mam- 
malian ANP has been used in such studies in fishes, and 
immunoreactive fish ANP has been measured only by 
heterologous radioimmunoassays (RIA) for mam- 
malian ANP [6]. 
We previously reported that mammalian ANP had 
little biological effect in eels, and that an RIA for 
human ANP did not measure l vels of eel ANP correct- 
ly [7]. Therefore, we isolated eel ANP from atria, deter- 
mined its amino acid sequence [8], and established a 
specific RIA for eel ANP [9]. The homologous RIA 
measured 700-fold higher values for ANP levels in eel 
atria than did the heterologous RIA for human ANP. 
Unexpectedly, however, levels of ANP it.~ eel cardiac 
ventricles were only a few-fold different between the 2 
measurements (unpublished data). Thus, it is likely that 
a different type of ANP is present in the eel ventricle, as 
was the case ~n the brain [10]. 
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2, MATERIALS AND METHODS 
The I~earts of cultured Japanese eels, Anguil/a japonica, were 
isolated immediately after decapitation and placed on ice. 'The ven- 
tricles were isolated from the still.b~ating hearts, and frozen im- 
mediately on dry ice, They were stored at =25°C until use. 
2,1. Extraction arid purification 
The ANP.lik¢ peptide, later named eel ventricular natrluretic pep- 
tide (VNP), was extracted from 2500 eel cardiac ventricles (225 8) as 
reported previously [8], in brief, the pulverized frozen tissues were 
boiled in water, acidified with AcOH. homogenized, and centrifuged, 
The supernatant was treated with 67°7o and 98.5O/o acetone to remove 
higl~-molecular.weight proteins and lipids, respectively. The crude ex- 
tract was subjected to gel.filtration ctlromatography on a column of 
Sephadex G-25 {Fig, In), cation-exchange chromatography on a col- 
umn of SP-Sephadex 025 (I ,6 × 15 cm), cation-exchange HPLC on 
an IEC.CM column (Fig. ib), and reverse.phase HPLC on an 
ODS-120T column (Fig, lc), The activity of VNP was assayed at each 
step by tneasuring relaxant activity in the chick rectum [I1], Semi- 
purified material was reduced and S.carboxymethylated, as described 
previously [8], and was finally purified by reverse-phase HPCL (Fig, 
ld), 
2.2, Analysis of amino acid sequence 
The amino acid sequence of the purified and carboxymethylated e l 
VNP was determined with an automated gas-phase protein sequencer 
(Applied Biosystems, Model 470A/120A), The correct sequence was 
verified by amino acid analysis with a PICO TAG Work Station 
(Waters), and by co.chromatography of the purified and synthetic 
peptide by reverse-phase HPLC with 2 different solvent systems [10], 
The eel VNP was synthesized with ~ peptide synthesizer (Applied 
Biosystems0 Model 430A), and its amino acid sequence was confirmed 
by the amino acid analyzer, seqt~encer and mass spectrometer [10], 
2,3, Relative bioactivity of eel VNP 
Procedures for the aaeasurement of arterial pressure in eels, and 
arterial pressure and renal sodium excretion in rats have beer. describ- 
ed previously [8], Eels (199 .t- 7 g, n = 8) were anesthetized and the 
ventral and dorsal aortae were cannulated for injections and 
measurements of blood pressure, respectively. Since eels became 
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Fig. I. (a) Gel.filtration chromatography on a column of Sephadex G.25 fine (5 x 82 cm). Sample, acid extract of eel ventricle; flow rate, 96 ml/h; 
eluent, I M AcOH; fraction size, 6,5 rnl/tube; Vo, votd volume; V .  total bed volume. Black bars represeat ctivities equivalent tc eel ANP in the 
chic k-rectum relaxant assay. Eel VNP was recovered from the peak I. (b} Cation-exchange high-performance liquid chromatography (HPLC) on 
ar IEC.CM column (7,5 x 75 ram, Jaseo, Tokyo), Sample, a fraction eluted witl~ pyridine-AcOH from a column of SP.Sephadex C-2S; flow rate, 
1 ml/rain; solvent system, linear-gradient elution from solvent A (10 mM Nl-.iaOAc, pH 6,8, plus CH)CN at a ratio of 9:1) to solvent B (1 M 
NH4OAc, pH 6,8, plus CH~CN at a ratio of 9:1); fraction size, 2 ml/tube, Each bioactive fraction was subjected to reverse-phase HPLC on a 
ODS- 120"I' column (4,6 × 250 ram, Tosoh, Tokyo) Eel V NP was recovered from the marked fractions. (c) Reverse-phase H PLC on an ODS- 120T 
column, Sample, bioactive fractions obtained from the first reverse-phase HPLC of the marked fractions in (b); flow rate, 1 tnl/min; solvent 
system, linear-gradient elution from CH3CN at a concentration f 20o7o to 40% in 0.1% trifluoroacetic a id for 40 rain. (d) Reverse.phase HPLC 
on an ODS.IIOT column. Sample, carboxymethylated materials in a bioactive fraction in (c), Other conditions arc identical to those described in 
(c). Fractions are collected by each peak. An arrow shows the peak of carboxymethylated VNP. 
unresponsive after the injection of high doses of eel VNP because of 
tachyphylaxis, the injections were started from the lowest dose, and 
intervals between injections of more than I h were introduced at high 
doses, Sprague-Dawley rats (286 ~- 3 g, n = 7) were anesthetized and 
the femoral vein was caanulated for injections and continuous infu- 
sions of a Ringer solution; the femoral artery was cannulated for 
measurement of blood pressure; and the urinary bladder was can- 
nulated for collection of urine. Urine volume, and urinary concentra- 
tions of sodium, potassium and chloride were measured. 
3. RESULTS AND DISCUSSION 
We have isolated, from eel cardiac ventricles, a 
highly basic peptide that exhibits a relaxant activity in 
the chick rectum after reduction and S- 
carboxymethylation of the semi-purified peptide (Fig. 
1). The yield was 8 txg equivalent to eel ANP by absor- 
bance at 220 nm. One half and one fifth of the carbox- 
ymethylated peptide were used, respectively, for the se- 
quence analysis and amino acid analysis, qlae remainder 
was used for the purity check and comparison of the se- 
quence with the synthetic peptide. The complete amino 
acid sequence of the carboxymethylated peptide was 
determined by the sequencer (Fig. 2). The result of 
amino acid analysis upports the sequence: Asp, 4.7 (5); 
CM-Cys, 2.4 (2); Set, 4.6 (5); Gly, 6.9 (6); Arg, 2.1 (2); 
Thr, 2.0 (2); Met, 0.9 (1); Ile, 1.9 (2); Leu, 2.2 (2); Phe, 
2.5 (3); Lys, 5.0 (5); Trp, undetectable (1). The values 
in perentheses are those obtained by the sequence 
analysis. Thus, this peptide consists of 36 amino acid 
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residues, including a tryptophane r sidue. The sequence 
thus deduced was finally confirmed by co- 
chromatography of the isolated and synthetic peptides 
in reverse-phase HPLC with different solvent systems, 
Since this peptide is a new type of natriuretic peptide 
which has long C-terminal 'tail' sequence (Fig. 3), and 
since this peptide was isolated from eel ventricles, we 
have named it venticular natriuretic peptide (VNP). 
Eel VNP caused hypotension i  conscious eels and 
natriaresis and hypotension i  anesthetized rats (Fig. 
Ee l  V~TP 
4). la the  homoiollous eel, eel VNP Is, like eel ANP and 
BNP, 100-fold more potent lh~in human ANP.  Unlike 
tile case with eel ANP and BNP, however, stronB 
tachyphylaxl~ w~s observed after injection of  VNP, end 
this reaction las~ed for several hours at hi i lh doses, 
Since the dose Biven at each injection was increased 
gradualty, the effect became smaller at higher doses 
(Fig. 4a}, Tachyphylaxis was also noted in association 
with the vasodepressor effect in rats after injection of 
VNP (data not shown). The natriuredc effect of eel 
VNP in rats was much stronger than the effects of eel 
ANP and BNP (Fig. 4b), Eel VNP also caused iuresis 
and chloridouresis, as well as antikaliuresis at high 
doses. It is noteworthy that tachyphylaxis was not 
observed in association with the natriuretic effect. 
The natriuretic peptides identified to date have been 
classified into 3 groups based on structural similarities 
and sites of production (Fig. 3). All members of the first 
group are isolated from atria and each is called ANP 
[8,12], The members of the second group are mostly 
called BNP because the first such peptide was isolated 
from the porcine brain [3]° even though all the other 
peptides and their messenger RNAs of this group were 
isolated from the heart [14-17]. Fowl ANP isolated 
from the heart [18] and bovine aldosterone s cretion i - 
hibitory factor (ASIF), isolated from cultural adrenal 
chromaffin cells [19], also belong to this group, The 
members of  the third group are all isolated from the 
brain and are called by various names. However, we 
shall call the members of this group C-type natriuretic 
peptide (CNP), because this name is used most fre- 
quently (Fig, 3). 
Three species of natriuretic peptides are found in 
KSFNS - CFGTRMDRZ G SWSGLGCN S L -KNGTKKKI  FGN 
A- type  Nat r iu re t i c  
Eel ANP 
Bu l l f rog  ANP 
Human ANP 
Rat ANP 
PeDt ide  
SKSSS PCFGGKLDRIG SY SG LGCNS-  RK  
SS  DCFG S R I DRIG AQ SG MGC -G -  RRF 
SLRRSS-  CFG GRMDRIG AQ SG LGCNS FR-  Y 
SLRRSS-  CFG GRIDRIGAQ SG LGCNSFR-  Y 
B-t~Lpe Nat r iu re t i c~ 
Fowl  ANP 
Porc ine  BNP 
Can ine  BNP 
Bov ine  AS IF  ~ 
Human BNP 
Rat BNP ~ 
MMRDSG-  CFG RRIDR~ GSL  SG MGCNGS RKN 
SPKTM-RDSG-  CFGRRLDRX GSL  SG LGCNVLRRY 
SPK-MMHKSG-CFGRRLDRI  GSL  SG LGCNVLRKY 
PK-MMRDSG-  CFGRRLDRI  GSL  SG LGCNVLRRY 
SPK-MVQGSG= CFGRKMDRZ SSS SG LGCKVLRRH 
S-K -MAHSS S-  CFGQKIDR~ GAV SR LGCE GLRLF  
C- type  Nat r iu re t i c  PeDt id~ 
Eel BNP GWNRG-  CFGLKLDRIGSL  SG~GC 
K i l ! i f i sh  bra in  ANP C-WNR~=-C_~C-L.~LDR=TGSMSG~GC 
Porc ine  CNP GLSKG=CFGLKLDR~GSMSG~GC 
Fig. 3. Comparison famino acid (single-letter code) sequences of eel VNP and other natriuretic peptides sequenced to date. Identical mino acid 
residues within the same group are printed in bold face. *These peptides have longer N-terminal mino-acid regions [19,22]. Gaps have been in- 
troduced to optimize matching, 
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eels, and  2 of them (eel ANP,  and eel BNP or CNP)  are 
classified as belonging to the A-type and ( . type  
natr iuret ie pep=ides (Fig, 3), Thus, it is possible that eel 
VNP belongs to the B-type natriuretic peptide, Com-  
paring the amino acid sequences, however,  no B-type 
natr iuret ic pep=ides have more than 6 amino  acids at the 
C-terminus which extend from the second half-cystine. 
Furthermore,  similarities in terms o f  amino  acid se- 
quences (present results) and of eDNA sequences (un- 
publ ished results) between eel VNP and the B-type 
natriuretlC peptides are no greater than such similarities 
to the A-type and C-type natriuretic pep=ides. Thus,  eel 
VNP may be a new type of natriuretic peptide. How- 
ever, we have to identify B-type natr iuret ic  peptide in 
the eel, and  the fourth peptide of a VNP type in mam- 
mals, to verify this assumption,  
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